Author: dxnimble

angiography alternative29Nov

Non-invasive Alternatives to Angiography: The Main Benefits
Currently, in today’s technology landscape, there is no easy way to ensure that a stent is functioning properly without resorting to an invasive procedure, the coronary angiography. To learn more about coronary angiography check out our previous article here. This procedure is not only costly but could also pose risks to the patient. That is why the medical community is eager to incorporate new technologies that offer non-invasive stent monitoring. This article will describe the current methods for diagnosing coronary stent malfunctions and highlight their main advantages and limitations. What …

NIMBLE Diagnostics CTO Susana Amorós: Leader of Innovation
NIMBLE Diagnostics has a strong collection of leaders steering its development and innovation as its technology succeeds expectations. Their CTO, Susana Amorós, sat down to discuss what brought her to the project, the next steps, and the inspiration that brought her to change lives. Amorós began her studies at UPC studying telecommunications engineering. However, during her last year, she discovered her passion — working in the medical sector of her field. With her degree, she would be able to aid in the design, testing, and manufacturing of medical equipment. Understanding …
nimble-diagnostics-stent11Jul

NIMBLE Diagnostics at Las Vegas Conference
MWC Conference in Las Vegas NIMBLE Diagnostics is proud to announce its invitation to the MWC Conference in Las Vegas. The MWC Conference celebrates innovation and human progress in technology development. NIMBLE Diagnostics plans to attend September 26-28th, 2023 to highlight its innovative technology and to network with other companies that are changing the game of the technology field as science continues to evolve. Not only will it offer an opportunity to share the revolutionary technology NIMBLE has been working on, but MWC Las Vegas will also allow NIMBLE access …
medical-alert-systems13Jun

NIMBLE Diagnostics: Non-invasive medical technology used to monitor patients with implanted coronary stents
Societal challenge: No method for proactively monitoring implanted stents NIMBLE Diagnostics’ novel technology will make waves in the medical community and in the treatment of cardiovascular disease. Atherosclerosis is the leading cause of most cardiovascular diseases, as it often forms blood clots and causes a restriction of oxygen-rich blood flow to the tissues. This blockage can cause various diseases, such as coronary artery disease, stroke, peripheral arterial disease, and aneurysms. Stents are small, metallic tubes implanted in the location of the obstruction to restore blood flow or other fluids. Initially, …
dayone-stent03Mar

NIMBLE Diagnostics: DayOne Innovation Summit
DayOne Innovation Summit 4FYN hosted by Fundacion la Caixa in Barcelona, Spain. At this conference, innovation and technology were celebrated in a gathering of ingenious companies aiming to change the world through technology and new ideas. Congratulations to Sycai Medical on their award, and we look forward to continuing to develop and change lives. …
nimble-diagnostics-cardiology-stent03Feb

Winner of Barcelona Activa Technology Grant
NIMBLE Diagnostics had recognition once more for its innovation and groundbreaking technology. This past week NIMBLE participated in and won first place in an accelerator program organized by Barcelona Activa and Grow Venture Partners. This program was created for early-stage technology projects, disruptive technologies, and technology in the validation stage in laboratory environments. NIMBLE competed against 7 selected projects and was judged by a panel of 4 experts, pushing the revolutionary technology to the final round where NIMBLE was judged by a panel of 19 professionals. After careful deliberation, NIMBLE was chosen for …
igtp-medicine-cardiac-stent15Ene

NIMBLE Diagnostics Closed Funding of Over 1 million Euros
Awarded 1.000.000 Euros NIMBLE Diagnostics’ funding has shown immense success. NIMBLE Diagnostics has successfully closed a funding round led by Grow Venture Partners together with Namarel Ventures and Inveniam Group. They have secured over 1 million euros to continue their mission of saving lives through preventative care. NIMBLE Diagnostics is a spin-off company of experts in the cardiology field of Germans Trias i Pujol Research Institute (IGTP), the Universitat Politècnica de Catalunya (UPC) – BarcelonaTech and the Universitat de Barcelona. They are all working together to create a medical technology device, the first of …

NIMBLE Diagnostics provides peace of mind to patients and clinicians by developing innovative medical devices.

  • IGTP Institut Germans Tries i Pujol
     Camí de les Escoles, s/n
    08916 Badalona, Barcelona
Explore
Contact us